PREMIUM
Health
New ARV injection offers two-month protection
Data from the trial showed a clear protective benefit from the drug, cabotegravir, with an 89% risk reduction.
New ARV injection offers two-month protection
By: NewVision Reporter, Journalists @NewVision
Uganda researchers are excited at the new results of a trial, which showed that an injectable ARV was highly effective in preventing HIV for two months.
On Tuesday, ViiV Healthcare, the